![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Kyongbo Pharmaceutical Co., Ltd. Asan-si Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Entacapone, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2015-168 - Rev 00
This Chemical Type CEP, issued on November 04, 2016, remains in force until July 12, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2574 associated with this CEP further emphasizes